Mutual Of America Capital Management LLC Krystal Biotech, Inc. Transaction History

Mutual Of America Capital Management LLC

$9.32 Billion
Q3 2024

A detailed history of Mutual Of America Capital Management LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 36,566 shares of KRYS stock, worth $5.79 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

36,566

Previous 37,324 2.03%

Holding current value

$5.79 Million

Previous $6.85 Million 2.99%

% of portfolio

0.07%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$174.7 - $213.66 $132,422 - $161,954	-758 Reduced 2.03%	36,566 $6.65 Million
Q2 2024 Aug 09, 2024	BUY	$153.12 - $183.64 $480,031 - $575,711	3,135 Added 9.17%	37,324 $6.85 Million
Q1 2024 May 02, 2024	SELL	$108.01 - $179.35 $237,513 - $394,390	-2,199 Reduced 6.04%	34,189 $6.08 Million
Q4 2023 Jan 26, 2024	SELL	$96.0 - $128.29 $110,496 - $147,661	-1,151 Reduced 3.07%	36,388 $4.51 Million
Q3 2023 Nov 09, 2023	SELL	$108.51 - $130.22 $104,386 - $125,271	-962 Reduced 2.5%	37,539 $4.35 Million
Q2 2023 Aug 11, 2023	BUY	$78.48 - $130.32 $1.02 Million - $1.69 Million	12,950 Added 50.68%	38,501 $4.52 Million
Q1 2023 May 04, 2023	SELL	$72.39 - $84.27 $85,203 - $99,185	-1,177 Reduced 4.4%	25,551 $2.05 Million
Q4 2022 Feb 10, 2023	BUY	$63.14 - $79.9 $23,046 - $29,163	365 Added 1.38%	26,728 $2.12 Million
Q3 2022 Nov 08, 2022	SELL	$64.85 - $82.4 $155,704 - $197,842	-2,401 Reduced 8.35%	26,363 $1.84 Million
Q2 2022 Aug 10, 2022	SELL	$48.93 - $73.47 $10,568 - $15,869	-216 Reduced 0.75%	28,764 $1.89 Million
Q1 2022 May 02, 2022	SELL	$51.99 - $72.11 $65,351 - $90,642	-1,257 Reduced 4.16%	28,980 $1.93 Million
Q4 2021 Feb 03, 2022	SELL	$39.81 - $88.24 $11,186 - $24,795	-281 Reduced 0.92%	30,237 $2.12 Million
Q3 2021 Nov 10, 2021	SELL	$52.01 - $71.77 $22,780 - $31,435	-438 Reduced 1.41%	30,518 $1.59 Million
Q2 2021 Aug 06, 2021	SELL	$62.14 - $81.82 $82,832 - $109,066	-1,333 Reduced 4.13%	30,956 $2.11 Million
Q1 2021 May 13, 2021	SELL	$59.42 - $85.46 $106,124 - $152,631	-1,786 Reduced 5.24%	32,289 $2.49 Million
Q4 2020 Feb 12, 2021	BUY	$40.64 - $61.38 $203,443 - $307,268	5,006 Added 17.22%	34,075 $2.04 Million
Q3 2020 Nov 13, 2020	BUY	$37.76 - $48.49 $99,610 - $127,916	2,638 Added 9.98%	29,069 $1.25 Million
Q2 2020 Aug 06, 2020	SELL	$37.03 - $60.0 $66,209 - $107,280	-1,788 Reduced 6.34%	26,431 $1.1 Million
Q1 2020 May 11, 2020	SELL	$35.02 - $65.64 $43,459 - $81,459	-1,241 Reduced 4.21%	28,219 $1.22 Million
Q4 2019 Feb 11, 2020	BUY	$33.17 - $65.23 $977,188 - $1.92 Million	29,460 New	29,460 $1.63 Million

Others Institutions Holding KRYS

# of Institutions

309

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.06B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Account

Mutual Of America Capital Management LLC Krystal Biotech, Inc. Transaction History